Xiao-I (AIXI) Responds To Deepseek Developments, Showcases Cost-Effective RL Breakthroughs In Hua Zang LLM, And Announces U.S. Expansion


(MENAFN- PR Newswire)

PISCATAWAY, N.J., Jan. 27, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI ), a leading artificial intelligence company ("Xiao-I"), today commented on recent developments surrounding "DeepSeek," emphasizing the company's longstanding expertise in reinforcement learning (RL) technology. The company highlighted how the firm has seamlessly integrated these advanced RL capabilities into its proprietary Hua Zang Large Language Model (LLM), offering a highly efficient solution that reduces both licensing and hardware costs.

Xiao-I's Hua Zang LLM leverages cutting-edge RL algorithms that the company has been refining for years-capabilities that have enabled the model to be deployed with minimal infrastructure outlay. The company underscored that the latest headlines around "DeepSeek" are unsurprising, given the company's ongoing research and innovation in advanced AI.

"As attention grows around new AI developments like DeepSeek, we want our investors and clients to know that Xiao-I has been quietly but diligently pushing the boundaries of reinforcement learning," said a company spokesperson. "Our Hua Zang LLM incorporates proprietary RL techniques, which deliver high performance and scalability, yet maintain a cost structure that sets us apart from other large language models. This efficiency has already proven itself in applications such as our recent HR digitization project for a Hong Kong government entity."

Hua Zang LLM's Advantages

  • Reinforcement Learning (RL) Core: Years of in-house R&D have culminated in a more efficient RL framework, optimizing training times and deployment costs.
  • Scalable Infrastructure: Achieves top-tier performance industry-specific model without requiring extensive, high-cost GPU clusters, lowering total cost of ownership for enterprise clients.
  • Competitive Licensing Model: Offers flexible, cost-effective licensing, making enterprise-scale LLM adoption accessible to organizations of all sizes.

Following success in Asia, Xiao-I now plans to expand its enterprise LLM solutions into the United States, tailoring its offerings to meet the dynamic needs of U.S. corporations seeking robust and budget-friendly AI services.

"We are excited to bring our cost-effective solutions to U.S. enterprises," continued the company spokesperson. "Our RL-optimized Hua Zang LLM addresses rising concerns about excessive hardware and licensing expenses, giving clients the freedom to scale AI initiatives without compromising on quality or performance."

About Xiao-I Corporation

Xiao-I Corporation is a leading cognitive intelligence enterprise in China that offers a diverse range of business solutions and services in artificial intelligence, covering natural language processing, voice and image recognition, machine learning, and affective computing. Since its inception in 2001, the Company has developed an extensive portfolio of cognitive intelligence technologies that are highly suitable and have been applied to a wide variety of business cases. Xiao-I powers its cognitive intelligence products and services with its cutting-edge, proprietary AI technologies to enable and promote industrial digitization, intelligent upgrading, and transformation. For more information, please visit: .

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to achieve its goals and strategies, the Company's future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions in China, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission ("SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, including under the section entitled "Risk Factors" in its annual report on Form 20-F filed with the SEC on April 30, 2024, as well as its current reports on Form 6-K and other filings, all of which are available for review at . The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

SOURCE Xiao-I Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN27012025003732001241ID1109134443


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.